These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 27626691

  • 21. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
    Mehrotra M, Luthra R, Abraham R, Mishra BM, Virani S, Chen H, Routbort MJ, Patel KP, Medeiros LJ, Singh RR.
    Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.
    Kato M, Nakamura H, Nagai M, Kubo T, Elzawahry A, Totoki Y, Tanabe Y, Furukawa E, Miyamoto J, Sakamoto H, Matsumoto S, Sunami K, Arai Y, Suzuki Y, Yoshida T, Tsuchihara K, Tamura K, Yamamoto N, Ichikawa H, Kohno T, Shibata T.
    Genome Med; 2018 Jun 07; 10(1):44. PubMed ID: 29880027
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
    Enyedi MZ, Jaksa G, Pintér L, Sükösd F, Gyuris Z, Hajdu A, Határvölgyi E, Priskin K, Haracska L.
    Oncotarget; 2016 Sep 20; 7(38):61845-61859. PubMed ID: 27533253
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Integrative molecular profiling of routine clinical prostate cancer specimens.
    Grasso CS, Cani AK, Hovelson DH, Quist MJ, Douville NJ, Yadati V, Amin AM, Nelson PS, Betz BL, Liu CJ, Knudsen KE, Cooney KA, Feng FY, McDaniel AS, Tomlins SA.
    Ann Oncol; 2015 Jun 20; 26(6):1110-1118. PubMed ID: 25735316
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.
    Conroy JM, Pabla S, Glenn ST, Seager RJ, Van Roey E, Gao S, Burgher B, Andreas J, Giamo V, Mallon M, Lee YH, DePietro P, Nesline M, Wang Y, Lenzo FL, Klein R, Zhang S.
    PLoS One; 2021 Jun 20; 16(12):e0260089. PubMed ID: 34855780
    [Abstract] [Full Text] [Related]

  • 31. Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens.
    Rathi V, Wright G, Constantin D, Chang S, Pham H, Jones K, Palios A, Mclachlan SA, Conron M, McKelvie P, Williams R.
    Pathology; 2017 Jan 20; 49(1):75-82. PubMed ID: 27913044
    [Abstract] [Full Text] [Related]

  • 32. Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
    Ross DS, Zehir A, Cheng DT, Benayed R, Nafa K, Hechtman JF, Janjigian YY, Weigelt B, Razavi P, Hyman DM, Baselga J, Berger MF, Ladanyi M, Arcila ME.
    J Mol Diagn; 2017 Mar 20; 19(2):244-254. PubMed ID: 28027945
    [Abstract] [Full Text] [Related]

  • 33. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
    Nachmanson D, Steward J, Yao H, Officer A, Jeong E, O'Keefe TJ, Hasteh F, Jepsen K, Hirst GL, Esserman LJ, Borowsky AD, Harismendy O.
    BMC Med Genomics; 2020 Nov 18; 13(1):173. PubMed ID: 33208147
    [Abstract] [Full Text] [Related]

  • 34. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J, Greco N, McNary TJ, Herrscher E, Wilkes D, MacDonald TY, Xue H, Vacic V, Emde AK, Oschwald D, Tan AY, Chen Z, Collins C, Gleave ME, Wang Y, Chakravarty D, Schiffman M, Kim R, Campagne F, Robinson BD, Nanus DM, Tagawa ST, Xiang JZ, Smogorzewska A, Demichelis F, Rickman DS, Sboner A, Elemento O, Rubin MA.
    JAMA Oncol; 2015 Jul 18; 1(4):466-74. PubMed ID: 26181256
    [Abstract] [Full Text] [Related]

  • 35. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.
    Wang SR, Malik S, Tan IB, Chan YS, Hoi Q, Ow JL, He CZ, Ching CE, Poh DYS, Seah HM, Cheung KHT, Perumal D, Devasia AG, Pan L, Ang S, Lee SE, Ten R, Chua C, Tan DSW, Qu JZZ, Bylstra YM, Lim L, Lezhava A, Ng PC, Wong CW, Lim T, Tan P.
    J Mol Diagn; 2016 May 18; 18(3):416-424. PubMed ID: 26970585
    [Abstract] [Full Text] [Related]

  • 36. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR, Pekmezci M, Bloomer MM, Cadenas NJ, Stevers M, Banerjee A, Roy R, Olshen AB, Van Ziffle J, Onodera C, Devine WP, Grenert JP, Bastian BC, Solomon DA, Damato BE.
    Ophthalmology; 2020 Jun 18; 127(6):804-813. PubMed ID: 32139107
    [Abstract] [Full Text] [Related]

  • 37. A novel machine learning approach (svmSomatic) to distinguish somatic and germline mutations using next-generation sequencing data.
    Mao YF, Yuan XG, Cun YP.
    Zool Res; 2021 Mar 18; 42(2):246-249. PubMed ID: 33709636
    [Abstract] [Full Text] [Related]

  • 38. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK, Hovelson DH, Demirci H, Johnson MW, Tomlins SA, Rao RC.
    Oncotarget; 2017 Jan 31; 8(5):7989-7998. PubMed ID: 28002793
    [Abstract] [Full Text] [Related]

  • 39. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
    Zhang L, Chen L, Sah S, Latham GJ, Patel R, Song Q, Koeppen H, Tam R, Schleifman E, Mashhedi H, Chalasani S, Fu L, Sumiyoshi T, Raja R, Forrest W, Hampton GM, Lackner MR, Hegde P, Jia S.
    Oncologist; 2014 Apr 31; 19(4):336-43. PubMed ID: 24664487
    [Abstract] [Full Text] [Related]

  • 40. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
    Garinet S, Néou M, de La Villéon B, Faillot S, Sakat J, Da Fonseca JP, Jouinot A, Le Tourneau C, Kamal M, Luscap-Rondof W, Boeva V, Gaujoux S, Vidaud M, Pasmant E, Letourneur F, Bertherat J, Assié G.
    J Mol Diagn; 2017 Sep 31; 19(5):776-787. PubMed ID: 28826610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.